BriaCell Provides Update On Alleged Illegal Trading Of Public Securities
Portfolio Pulse from Benzinga Newsdesk
BriaCell Therapeutics Corp. (NASDAQ:BCTX, TSX:BCT) has provided an update on its investigation into alleged illegal trading of its securities. The company reported significant settlement share imbalances after forensic analysis and discussions with prime brokers, leading to formal complaints with FINRA and CIRO. BriaCell is committed to combating these manipulative trading activities and will provide further updates.
February 27, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BriaCell Therapeutics Corp. is actively investigating alleged illegal trading of its securities, with formal complaints filed with regulatory authorities.
The investigation into illegal trading activities directly involves BriaCell and its securities. While the outcome is uncertain, the company's proactive stance and formal complaints to regulatory bodies could reassure investors. However, the ongoing investigation may also bring volatility to the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100